The nation of Zimbabwe has declined a major US health deal worth 367 million US dollars (£272m) spanning five years due to Washington's insistence on confidential data.
This rejection came to light after a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesperson has since explained that the United States was seeking biological samples for research and commercial gain while refused to guarantee the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged continued negotiations to find a agreement agreeable to both sides so the country's vital HIV programme can continue.
Wider Context
This rejection comes after a comparable situation in Kenya, where a high court blocked a similar deal with the US following legal challenges were raised about the safety of citizens' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government agreements to boost openness and accountability.
As per reports, 16 African countries have so far agreed to these new health pacts, representing over $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to provide its biological resources and data over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," he stated.
"Effectively, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our people should a future pandemic emerge."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining systems already set up via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This mechanism is intended to guarantee that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the capability to create them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome ongoing discussions with our US partners on how subsequent co-operation could be structured in a way that honours the sovereignty and interests of both nations."
Medical Community Response
A leading public health body expressed it recognised the official position, but suggested that talks need to persist considering a large portion of the nation's Aids initiatives depended on external financing.
"In cases where specific concerns arise, such as those relating to information security or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group commented.
This impasse emphasises the ongoing tensions between accepting much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.